DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Cheng A.
Phase III trial of lenvatinib (LEN) vs sorafenib (SOR) in first-line treatment of patients (pts) with unresectable hepatocellular carcinoma (uHCC).
2017 ASCO Annual Meeting Abstracts [Internet]. Available at:
http://abstracts.asco.org/199/AbstView_199_186143.html . Accessed June 26, 2017
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.